Dysbiosis and Staphylococcus aureus Colonization Drives Inflammation in Atopic Dermatitis.

[1]  S. Feldman,et al.  Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. , 2014, Journal of the American Academy of Dermatology.

[2]  Mayte Suárez-Fariñas,et al.  Immunology of psoriasis. , 2014, Annual review of immunology.

[3]  G. K. Khurana Hershey,et al.  EGFR Signaling Blunts Allergen-Induced IL-6 Production and Th17 Responses in the Skin and Attenuates Development and Relapse of Atopic Dermatitis , 2014, The Journal of Immunology.

[4]  Jing Wang,et al.  Topical hypochlorite ameliorates NF-κB-mediated skin diseases in mice. , 2013, The Journal of clinical investigation.

[5]  Julia Oh,et al.  The altered landscape of the human skin microbiome in patients with primary immunodeficiencies , 2013, Genome research.

[6]  S. Steinberg,et al.  Genetic Ablation of Epidermal EGFR Reveals the Dynamic Origin of Adverse Effects of Anti-EGFR Therapy , 2013, Science Translational Medicine.

[7]  J. Fischer,et al.  Epidermal EGFR Controls Cutaneous Host Defense and Prevents Inflammation , 2013, Science Translational Medicine.

[8]  M. Suárez-Fariñas,et al.  Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. , 2013, The Journal of allergy and clinical immunology.

[9]  S. Spector,et al.  Atopic dermatitis: a practice parameter update 2012. , 2013, The Journal of allergy and clinical immunology.

[10]  M. Suárez-Fariñas,et al.  Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. , 2012, The Journal of allergy and clinical immunology.

[11]  N. Polissar,et al.  Development and validation of the Canine Atopic Dermatitis Lesion Index, a scale for the rapid scoring of lesion severity in canine atopic dermatitis. , 2012, Veterinary dermatology.

[12]  Julia Oh,et al.  Shifts in human skin and nares microbiota of healthy children and adults , 2012, Genome Medicine.

[13]  C. Deming,et al.  Compartmentalized Control of Skin Immunity by Resident Commensals , 2012, Science.

[14]  M. Blaser,et al.  Antibiotics in early life alter the murine colonic microbiome and adiposity , 2012, Nature.

[15]  Keisuke Nagao,et al.  Brief Report: Requirement of TACE/ADAM17 for Hair Follicle Bulge Niche Establishment , 2012, Stem cells.

[16]  H. Mizuno,et al.  Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice. , 2012, The Journal of allergy and clinical immunology.

[17]  K. Horiuchi,et al.  Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand–dependent terminal keratinocyte differentiation , 2012, The Journal of experimental medicine.

[18]  M. Nordenskjöld,et al.  Characterization of EGFR and ErbB2 expression in atopic dermatitis patients , 2012, Archives of Dermatological Research.

[19]  Julia Oh,et al.  Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis , 2012, Genome research.

[20]  Keisuke Nagao,et al.  Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. , 2012, The Journal of clinical investigation.

[21]  S. Molyneux,et al.  Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis. , 2012, Immunity.

[22]  Tetsuro Kobayashi,et al.  Langerhans cell antigen capture through tight junctions confers preemptive immunity in experimental staphylococcal scalded skin syndrome. , 2011, The Journal of experimental medicine.

[23]  Wei-Li Di,et al.  Inflammatory skin and bowel disease linked to ADAM17 deletion. , 2011, The New England journal of medicine.

[24]  A. Irvine,et al.  Filaggrin mutations associated with skin and allergic diseases. , 2011, The New England journal of medicine.

[25]  Gautam Dantas,et al.  Antibiotics and the resistant microbiome. , 2011, Current opinion in microbiology.

[26]  J. Berman,et al.  Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. , 2011, Immunity.

[27]  Richard A. Flavell,et al.  NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis , 2011, Cell.

[28]  B. Finlay,et al.  Shifting the balance: antibiotic effects on host–microbiota mutualism , 2011, Nature Reviews Microbiology.

[29]  H. Williams,et al.  Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review , 2010, The British journal of dermatology.

[30]  M. Lacouture,et al.  Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy. , 2010, Journal of the National Cancer Institute.

[31]  M. Amagai,et al.  External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers , 2009, The Journal of experimental medicine.

[32]  Dan R. Littman,et al.  Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.

[33]  Lisa C. Zaba,et al.  IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. , 2009, The Journal of allergy and clinical immunology.

[34]  C. Deming,et al.  Topographical and Temporal Diversity of the Human Skin Microbiome , 2009, Science.

[35]  A. Rademaker,et al.  Treatment of Staphylococcus aureus Colonization in Atopic Dermatitis Decreases Disease Severity , 2009, Pediatrics.

[36]  Clare L. Bennett,et al.  Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions , 2009, Proceedings of the National Academy of Sciences.

[37]  K. Horiuchi,et al.  Of Il-17 and G-csf Increased Granulopoiesis via Dysregulation Promoter Leads to Osteoporosis and Sox9 Conditional Inactivation of Tace by a Blobel and Yoshiaki Toyama , 2022 .

[38]  F. Ginhoux,et al.  Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells , 2008, Nature Reviews Immunology.

[39]  H. Takada,et al.  Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome , 2007, Nature.

[40]  W. Chey,et al.  American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection , 2007, The American Journal of Gastroenterology.

[41]  Gerard D. Wright.  The antibiotic resistome: the nexus of chemical and genetic diversity , 2007, Nature Reviews Microbiology.

[42]  T Rokkas,et al.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report , 2006, Gut.

[43]  M. Lacouture.  Mechanisms of cutaneous toxicities to EGFR inhibitors , 2006, Nature Reviews Cancer.

[44]  Colin N A Palmer,et al.  Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis , 2006, Nature Genetics.

[45]  M. Shlomchik,et al.  Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. , 2005, Immunity.

[46]  A. Paller,et al.  Atopic dermatitis and the atopic march. , 2003, The Journal of allergy and clinical immunology.

[47]  Koichiro Nakamura,et al.  Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. , 2001, The Journal of allergy and clinical immunology.

[48]  C. Bodemer,et al.  Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome , 2000, Nature Genetics.

[49]  David C. Lee,et al.  An essential role for ectodomain shedding in mammalian development. , 1998, Science.

[50]  S. Lemay,et al.  Efficacy of Enrofloxacin in the Treatment of Canine Bacterial Pyoderma. , 1990, Veterinary dermatology.

[51]  J. Leyden,et al.  Staphylococcus aureus in the lesions of atopic dermatitis , 1974, The British journal of dermatology.

[52]  古賀 千律子.  Possible pathogenic role of Th17 cells for atopic dermatitis , 2011 .

[53]  C. Blobel,et al.  ADAMs: key components in EGFR signalling and development , 2005, Nature Reviews Molecular Cell Biology.

[54]  N. Stollman,et al.  Diagnosis and management of diverticular disease of the colon in adults. Ad Hoc Practice Parameters Committee of the American College of Gastroenterology. , 1999, The American journal of gastroenterology.